You have 9 free searches left this month | for more free features.

Hodgkin Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brazilian Prospective Hodgkin Lymphoma Registry

Recruiting
  • Hodgkin Lymphoma
  • Hodgkin Disease
    • Rio de Janeiro, Brazil
      Universidade Federal Do Rio de Janeiro
    May 16, 2022

    Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Trial in United States (CD30.CAR-T, Fludarabine,

    Active, not recruiting
    • Hodgkin Lymphoma, Adult
    • +3 more
    • Duarte, California
    • +4 more
    Apr 3, 2022

    Hodgkin's Disease Trial in Boston (Echo/Stress Echo)

    Active, not recruiting
    • Hodgkin's Disease
    • Echo/Stress Echo
    • Boston, Massachusetts
    • +1 more
    Mar 28, 2022

    Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in

    Completed
    • Hodgkin's Disease
      • Louisville, Kentucky
        Norton Cancer Institute
      Dec 14, 2021

      Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin

      Recruiting
      • Hodgkin Lymphoma
        • Naples, Italy
          Federico II University
        Feb 15, 2022

        Non-Hodgkin's Lymphoma and Hodgkin's Disease

        Recruiting
        • Lymphoma, Non-Hodgkin
        • Hodgkin's Disease
          • Stanford, California
            Stanford University School of Medicine
          Aug 2, 2021

          Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

          Active, not recruiting
          • Hodgkin Lymphoma
          • Brentuximab Vedotin
          • +3 more
          • Valhalla, New York
            New York Medical College
          Oct 29, 2021

          Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Stony Brook, Nashville (TG-0054 combined with G-CSF)

          Completed
          • Multiple Myeloma
          • +2 more
          • TG-0054 combined with G-CSF
          • Stony Brook, New York
          • +1 more
          Apr 14, 2021

          Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)

          Completed
          • Multiple Myeloma
          • +2 more
          • Stony Brook, New York
            Stony Brook University Hospital
          Apr 14, 2021

          Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Taiwan (TG-0054 (2.24 mg/kg), TG-0054 (3.14 mg/kg))

          Completed
          • Multiple Myeloma
          • +2 more
          • TG-0054 (2.24 mg/kg)
          • TG-0054 (3.14 mg/kg)
          • Chiayi, Taiwan
          • +5 more
          Apr 14, 2021

          Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

          Recruiting
          • Young Adults
          • +2 more
          • Indirect calorimetric test during submaximal exercise
          • Clermont-Ferrand, France
            CHU de Clermont-Ferrand
          May 3, 2022

          Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

          Not yet recruiting
          • Hodgkin Lymphoma
          • Brentuximab Vedotin
          • (no location specified)
          Jul 28, 2022

          Hodgkin Lymphoma, Lung Cancer Trial in Manchester (Low dose CT thorax)

          Enrolling by invitation
          • Hodgkin Lymphoma
          • Lung Cancer
          • Low dose CT thorax
          • Manchester, United Kingdom
            The Christie NHS Foundation Trust
          Mar 10, 2022

          Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

          Recruiting
          • Classical Hodgkin Lymphoma
          • +2 more
          • Duarte, California
          • +4 more
          Jun 27, 2022

          Thereapeutic Recommendantion for a Hodgkin Lymphoma

          Not yet recruiting
          • Staging
          • Therapeutic Recommendations
          • Observational
          • Paris, France
            Brenda Mallon
          Jul 20, 2022

          Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

          Not yet recruiting
          • Classical Hodgkin Lymphoma
          • Cologne, Germany
            1st Department of Medicine, Cologne University Hospital
          Aug 5, 2022

          Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

          Active, not recruiting
          • Hodgkin Lymphoma
          • pembrolizumab
          • brentuximab vedotin
          • (no location specified)
          Aug 18, 2022

          Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

          Recruiting
          • Non-Hodgkin Lymphoma
          • Hodgkin Lymphoma
          • Minneapolis, Minnesota
            Masonic Cancer Center, University of Minnesota
          Jan 3, 2022

          Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

          Recruiting
          • Lymphoma
          • +3 more
          • New York, New York
            Columbia University
          Apr 27, 2022

          Biospecimen Procurement for Center for Immuno-Oncology

          Recruiting
          • Multiple Myeloma
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jul 13, 2022

            Health and Screening Tests in People Treated for Hodgkin

            Completed
            • Hodgkin Lymphoma
              • Manchester, United Kingdom
                The Christie NHS Foundation Trust
              Sep 28, 2021

              Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

              Terminated
              • Hodgkin Disease
              • Lymphoma, Non-hodgkin
              • New York, New York
                Columbia University Irving Medical Center - Center for Lymphoid
              Jun 28, 2021

              Hodgkin Lymphoma Trial in New York (Mocetinostat Plus Brentuximab Vedotin)

              Completed
              • Hodgkin Lymphoma
              • Mocetinostat Plus Brentuximab Vedotin
              • New York, New York
                Memorial Sloan Kettering Cancer Center
              May 10, 2022

              Hodgkin Lymphoma Trial (pembrolizumab)

              Active, not recruiting
              • Hodgkin Lymphoma
              • pembrolizumab
              • (no location specified)
              May 30, 2022